Drug recall · October 10, 2012
Nimodipine Capsules 30 mg recall
Why: Crystallization: Presence of crystals of Nimodipine within the capsule solution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.
- Lots / codes
Lot: a) 3305.039B, Exp 07/13; b) 3305.039A, Exp 07/13
- Quantity
- a) 2424 Cartons b) 2675 Cartons
- Company
- Caraco Pharmaceutical Laboratories Ltd., Cranbury, NJ
- Distribution
- One direct account - Caraco Pharmaceutical Labroatories, LTD Detroit, Michigan 78 sub accounts
- Initiated
- August 21, 2012 · Voluntary: Firm initiated
- Classified
- October 3, 2012
- Reported
- October 10, 2012
- Ended
- November 19, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nimodipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.